The case for induced pluripotent stem cell‐derived cardiomyocytes in pharmacological screening
Publisher: John Wiley & Sons Inc
E-ISSN: 1476-5381|169|2|304-317
ISSN: 0007-1188
Source: BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.169, Iss.2, 2013-05, pp. : 304-317
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract